12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Angiochem, GlaxoSmithKline deal

The companies partnered to discover, develop and commercialize therapies that cross the blood brain barrier to treat neurological symptoms of lysosomal storage diseases by restoring enzyme function in the CNS. Angiochem will develop...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >